0 Views
0 Likes
0 Shares
0 Comments
Read article ↗

StayCurrentMD

View profile →

Article

Commentary on Endoscopic Chemocauterization with Trichloroacetic Acid for Congenital or Recurrent Tracheoesophageal Fistula in Children with Esophageal Atresia: Experience from a Tertiary Center

Published: Reading: 1 min

Topic overview

This commentary examines endoscopic chemocauterization using trichloroacetic acid as a minimally invasive alternative to surgical re-intervention for managing congenital and recurrent tracheoesophageal fistulas in children with esophageal atresia. The approach addresses the challenge of surgical complications and recurrence rates in this patient population.

Key takeaways

  • Endoscopic chemocauterization with trichloroacetic acid offers a minimally invasive alternative for TEF management in esophageal atresia patients.
  • Surgical repair of TEF, while gold standard, carries risk of severe complications and recurrence even after definitive treatment.
  • Endoscopic approaches are traditionally reserved for recurrent TEF cases, with limited published evidence on efficacy and outcomes.
  • The Stockholm series adds to sparse literature on chemical ablation techniques for both congenital and recurrent tracheoesophageal fistulas.

Keywords

Hashtags

Full article text

Full article text not available for this entry
How to cite: GlobalCastMD. Commentary on Endoscopic Chemocauterization with Trichloroacetic Acid for Congenital or Recurrent Tracheoesophageal Fistula in Children with Esophageal Atresia: Experience from a Tertiary Center. GlobalCastMD Medical Library. 2023-12-05. https://library.globalcastmd.com/article/8287

Comments

Loading comments...